ABUS vs SJM · P/E 5.4, rev $6.2M vs $11.10B cap
Arbutus Biopharma Corp (ABUS) versus JM Smucker Company (SJM) — a side-by-side from cached financials, not a winner call.
Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.
JM Smucker Company (SJM) is a packaged foods company listed on US.
Latest reported ABUS revenue for 2024-12-31 was $6.2M. Net income was -$69.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. ABUS currently screens at market cap $883.0M and trailing P/E 5.4.
SJM does not have a complete income-statement cache yet.
ABUS currently screens at market cap $883.0M and trailing P/E 5.4. SJM currently screens at market cap $11.10B.
Not investment advice. Open the ABUS and SJM stock pages for the full models.
Not investment advice.